Plain-English translation of NCT02761200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a safety and monitoring study for people with HIV who recently completed a research trial that included a planned break from antiretroviral therapy (the standard HIV medications). Researchers want to carefully track your health and viral levels after stopping treatment to understand what happens and make sure you stay safe. Depending on your individual situation, you may restart your HIV medications or continue being monitored off treatment.
Some HIV research programs intentionally pause medications for a limited time to study the virus and immune system. This follow-up study exists to ensure people who participated in those trials are safe afterward and to understand how quickly the virus returns and how the body responds when treatment restarts.
You likely qualify if…
You likely don't qualify if…
You will have regular clinic visits over about 3 years to have blood tests and check-ups that monitor your HIV virus levels and immune system. Depending on your results and preferences, you may restart your HIV medications during the study, or continue without them while being closely watched. You may also be offered optional procedures like additional blood work or imaging scans if you want to participate in additional research.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Thailand
Sponsor
SEARCH Research Foundation
Collaborators
US Military HIV Research Program
Enrollment target
~100 participants
Started
March 2016
Primary completion
March 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Somchai Sriplienchan, MD, MPH
SEARCH Research Foundation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.